In Pharma companies, what is the practice for RR and UD authorisation
means we need to create different groups for recording the result, valuate the result by another gr and UD by 3rd group (pur/prod)
My question is Lab people authorise to do UD stock posting ???
Follow up action for automatic stock posting can be assigned for UD codes ....
what is normal practice........
Please throw some light